Join Us: We Work For Health Hosts Special Event About the Ongoing Threats of the IRA

Learn about the Inflation Reduction Act—and how it’s threatening America’s biopharmaceutical ecosystem and our nation’s Medicare-aged population—at a special event sponsored by We Work For Health. The April 10 event will feature a panel discussion with experts and unveil new research that shows a clear drop in early-state investment in small-molecule drugs—pills and tablets—especially those treatments meant for seniors.

Don’t miss this opportunity to hear from key experts, including lead sponsors of the EPIC Act, as we discuss the future of medical innovation.

Safeguarding Medical Breakthroughs: The EPIC Act as a Path Forward

Thursday, April 10, 12:30-1:30 pm ET

Hear from:

Keynote Remarks from Representatives Greg Murphy (R-NC) &
Don Davis (D-NC)
Dan Leonard, Executive Director of We Work For Health
Duane Schulthess, CEO of Vital Transformation
Adina Lasser, Director of Public Policy at Alliance for Aging Research
Ipsita Smolinski, Founder and Managing Director of Capitol Street

The panelists will share insights and groundbreaking research into how the IRA's pill penalty is already negatively impacting small-molecule drug development and healthcare accessibility for seniors, and how the recently introduced EPIC Act offers a solution.

Lunch will be provided.